+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genentech, Inc.  - logo

Genentech, Inc., a biotechnology company, engages in the research, development, manufacture, and marketing of biotechnology products for treating patients with serious or life-threatening diseases in the United States. It offers molecular entities and medicines in the areas of oncology, immunology, neuroscience, metabolism, and infectious diseases. The company was founded in 1976 and is headquartered in South San Francisco, California. Genentech operates as a subsidiary of Roche Holdings, Inc.

Hidradenitis Suppurativa Global Market Report 2024 - Product Thumbnail Image

Hidradenitis Suppurativa Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Licensing Deals in Biotechnology 2019-2024 - Product Thumbnail Image

Licensing Deals in Biotechnology 2019-2024

  • Report
  • September 2024
  • 1250 Pages
  • Global
From
Collaboration Deals in Biotechnology 2019-2024 - Product Thumbnail Image

Collaboration Deals in Biotechnology 2019-2024

  • Report
  • September 2024
  • 1200 Pages
  • Global
From
From
Cystic Fibrosis (CF) Therapeutics Global Market Report 2024 - Product Thumbnail Image

Cystic Fibrosis (CF) Therapeutics Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Nasal Polyps Treatment Global Market Report 2024 - Product Thumbnail Image

Nasal Polyps Treatment Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
From
From
From
Primary Sclerosing Cholangitis - Pipeline Insight, 2024 - Product Thumbnail Image

Primary Sclerosing Cholangitis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
From
From
From
From
Loading Indicator